✦ LIBER ✦

Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed/refractory multiple myeloma with severe heart failure

✍ Scribed by Zhou, Fan; Ling, Chenhui; Guo, Lieping; Wei, Wei; Li, Lu; Shi, Haotian; Hou, Jian

Book ID: 121485917
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 813 KB
Volume: 55
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2014.887711

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continuous Administration of Low-Dose Cy

Continuous Administration of Low-Dose Cyclophosphamide and Prednisone as a Salvage Treatment for Multiple Myeloma

✍ Fan Zhou; Lieping Guo; Haotian Shi; Chenhui Lin; Jian Hou 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 117 KB

Bortezomib in combination with intermedi

Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma

✍ Martin Kropff; Guido Bisping; Elke Schuck; Peter Liebisch; Nicola Lang; Markus H 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Continuous low-dose cyclophosphamide–pre

Continuous low-dose cyclophosphamide–prednisone is effective and well tolerated in patients with advanced multiple myeloma

✍ Okke de Weerdt; Niels W.C.J van de Donk; Gerda Veth; Andries C Bloem; Anton Hage 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Bendamustine and prednisone in combinati

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure

✍ Pönisch, Wolfram; Moll, Barbara; Bourgeois, Malvina; Andrea, Marc; Schliwa, Thom 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 336 KB

The use of low-dose prednisone and melph

The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma

✍ Cuttner, Janet ;Wasserman, L. R. ;Martz, Georg ;Sonntag, Roland W. ;Kyle, Robert 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

## Abstract A study was designed to evaluate the effectiveness of prednisone therapy in poor‐risk patients with multiple myeloma. Patients were treated with melphalan alone or in combination with prednisone at doses of either 0.6 mg/kg or 0.3 mg/ kg. The group of patients receiving melphalan and pr

Low-dose thalidomide in combination with

Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma

✍ Charalampia Kyriakou; Kirsty Thomson; Shirley D'Sa; Angela Flory; Judith Hanslip 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB